$19.5M Abilify Improper Marketing Settlement Obtained by 43 States
States Allege BMS Marketed Abilify Antipsychotic to Children, Elderly. In a multistate settlement, Bristol-Myers Squibb agreed to pay $19.5 million to settle allegations of improper marketing with its atypical antipsychotic drug, Abilify. The drug maker allegedly marketed Abilify to children and the elderly, even though … [Read more...] about $19.5M Abilify Improper Marketing Settlement Obtained by 43 States
$19.5M Abilify Improper Marketing Settlement Obtained by 43 States
States Allege BMS Marketed Abilify Improper Marketing Antipsychotic to Children, Elderly. In a multistate settlement, Bristol-Myers Squibb agreed to pay $19.5 million to settle allegations of improper marketing with its atypical antipsychotic drug, Abilify. The drug maker allegedly marketed Abilify to children and the elderly, even … [Read more...] about $19.5M Abilify Improper Marketing Settlement Obtained by 43 States
L’Oreal Warned by FDA for Improper Marketing
FDA Warning Letter To L’Oreal Marketing. The U.S. Food and Drug Administration (FDA) has issued a February 12 warning letter to L'Oreal for the improper marketing of its Rosaliac AR Intense and Mela-D Pigment Control. According to Regulatory Affairs Professionals Society (RAPS), the agency said these products are being … [Read more...] about L’Oreal Warned by FDA for Improper Marketing
FDA Warns L’Oréal about Improper Marketing of Skin Care Products
The Food and Drug Administration (FDA) has warned cosmetic giant L’Oréal, for the second time in three years, about improper marketing of skin care products. Cosmetic products are not subject to the same scrutiny and regulation as drugs, but cosmetics are limited in the types of claims they can make to consumers, according to … [Read more...] about FDA Warns L’Oréal about Improper Marketing of Skin Care Products
Improper Pharmacia Marketing
Pharmacia Corp. Improper Marketing. A consumer group sued Pharmacia Corp. over its promotion of the pain drug Bextra, alleging that the pharmaceutical company is circumventing federal marketing regulations. The Congress of California Seniors filed the suit in California Superior Court in Los Angeles on Monday, alleging … [Read more...] about Improper Pharmacia Marketing
